Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

785.03 -6.21 (-0.78%)
Official Closing Price Updated: 7:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,442,940
Open 789.95
Bid (Size) 781.02 (1)
Ask (Size) 785.15 (2)
Prev. Close 791.24
Today's Range 779.44 - 790.62
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.76%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Gilead Sciences Wins Approval For Highly Effective HIV Prevention Drug
The drug will sell under the brand name Yeztugo. In clinical testing, it kept 99.9% of patients from contracting HIV. 
Via Investor's Business Daily
Scholar Rock Stock Soars After Investigational Drug Helps Preserve Lean Mass: Retail Flags Lack Of Incremental Weight Loss
Apitegromab therapy with Tirzepatide preserved an additional 4.2 pounds of lean mass compared to Tirzepatide alone in the study, the company said. 
Via Stocktwits
Topics Death
Exposures Death

Performance

YTD
+0.9%
+0.9%
1 Month
+4.0%
+4.0%
3 Month
-6.2%
-6.2%
6 Month
+2.7%
+2.7%
1 Year
-11.9%
-11.9%

More News

Read More
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
Via Benzinga
Why Scholar Rock Shares Are Soaring Today
Via The Motley Fool
Topics Stocks
Exposures US Equities
Is the Market Bullish or Bearish on Eli Lilly?
Via Benzinga
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
Via Benzinga
Nobody Wants To Touch Healthcare Stocks Now – That Might Be A Big Mistake
Via Benzinga
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Via The Motley Fool
Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
Market Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN)
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Verve Therapeutics Stock Is Skyrocketing Today
Via The Motley Fool
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal
Via Stocktwits
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks
Via The Motley Fool
Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’
Via Stocktwits
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
Via Investor's Business Daily
Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition
Via Benzinga
May 2025 Industrial Manufacturing Near March 2025 Levels with 146 New Planned Capital Projects Heading into Summer
Via Send2Press
Verve Therapeutics Soars 75% After-Hours Following Report Of $1.3B Eli Lilly Takeover Talks
Via Stocktwits
Why Novo Nordisk Stock Sank by Nearly 4% Today
Via The Motley Fool
These 2 Growth Stocks Are No-Brainer Buys Right Now
Via The Motley Fool
Could Meta and Eli Lilly Trigger the Next Stock Split Boom?
Via MarketBeat
Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499
Via Benzinga
Eli Lilly To Offer Highest Doses Of Weight-Loss Medicine On Its Digital Health Platform, But Retail Wants More Good News
Via Stocktwits
Topics Stocks
Exposures US Equities

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 785.03
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 06/18/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.